Mountain Valley MD Holdings Inc. (CNSX: MVMD)
Health Care · Pharmaceuticals · CA
CA$0.08
+36.36% today · +400.0% 1Y
Mountain Valley MD Holdings Inc. (CNSX: MVMD) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $24.89M and employs 1 people.
Over the last twelve months the share price has gained 400.0%, trading between 0.01 and 0.11.
Tweenvest scores Mountain Valley MD Holdings Inc. across four factors: quality 11/100, value 68/100. Its strongest factor is value.
MVMD price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $24.89M
- Revenue (TTM)
- $46.57K
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- -2.72
- 52-week high
- CA$0.11
- 52-week low
- CA$0.01
- Avg volume (3M)
- —
- Shares outstanding
- 457.00M
- Employees
- 1
- Next earnings
- —
About Mountain Valley MD Holdings Inc.
Mountain Valley MD Holdings Inc., operating through its subsidiary Mountain Valley MD Inc., functions as a health and wellness enterprise. The company focuses on deploying and licensing its proprietary innovations to external entities within the pharmaceutical, vaccine, and nutritional supplement sectors. Its portfolio encompasses Quicksome, an advanced technology for oral drug formulation and delivery; Quicksol, designed for enhancing solubility; and a dose-sparing adjuvant. Additionally, the firm is actively developing IM032, a compound currently being evaluated in male beagle dogs to assess intramuscular versus subcutaneous administration methods. Mountain Valley MD Holdings Inc. is headquartered in Concord, Canada.
- ISIN
- CA6165361081
- Listed since
- Mar 2, 2020
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,231.78 | -0.15% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $272.81 | -0.12% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $155.85 | -0.38% |
| Roche Holding AGSWX: ROP | $371.62B | CHF371.90 | -0.51% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.29 | -1.18% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.51 | -0.21% |
Figures last refreshed Aug 18, 2026.